Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing: Implications for gene therapy

This publication has 24 references indexed in Scilit:

• Pancreatic Cancer
  Drugs, 2000
• Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene
  Gene Therapy, 1999
• In vivo Adenovirus‐mediated Prodrug Gene Therapy for Carcinoembryonic Antigen‐producing Pancreatic Cancer
  Japanese Journal of Cancer Research, 1998
• The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions
  Gene Therapy, 1997
• Pancreatic Carcinoma Cell Killing Via Adenoviral Mediated Delivery of the Herpes Simplex Virus Thymidine Kinase Gene
  Annals of Surgery, 1997
• Connections with Connexins: the Molecular Basis of Direct Intercellular Signaling
  European Journal of Biochemistry, 1996
• In VitroEvidence That Metabolic Cooperation Is Responsible for the Bystander Effect Observed with HSVtkRetroviral Gene Therapy
  Human Gene Therapy, 1993
• In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors
  Science, 1992
• Pancreatic Carcinoma
  New England Journal of Medicine, 1992
• Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1.
  Proceedings of the National Academy of Sciences, 1983